← FDA Drug Approvals (Drugs@FDA)

AVALIDE

NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1997-09-30

Drug application

FDA Application #
NDA020758
Application type
New Drug Application
Brand name
AVALIDE
Generic name
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Active ingredients
HYDROCHLOROTHIAZIDE; IRBESARTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
SANOFI AVENTIS US
Manufacturer
Sanofi-Aventis U.S. LLC
First approval
1997-09-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown